Mathias Hukkelhoven
Director/Board Member bij COMPUGEN LTD.
Vermogen: - $ op 31-03-2024
Profiel
Mathias Hukkelhoven is an Independent Director at Compugen Ltd.
and an Independent Non-Executive Director at Centessa Pharmaceuticals Plc.
He previously worked as the Chairman-Portfolio Stewardship at Novartis Pharmaceuticals Corp.
and as the Senior VP-Global Head Drug Regulatory Affairs at Novartis Pharmaceuticals Corp.
from 2001 to 2009.
He also served as the SVP-Global Regulatory, Safety & Biometrics at Bristol-Myers Squibb (Israel) Ltd.
from 2010 to 2021.
Dr. Hukkelhoven obtained his undergraduate and doctorate degrees from Radboud University Nijmegen.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 22-06-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Mathias Hukkelhoven
| Bedrijven | Functie | Begin |
|---|---|---|
| COMPUGEN LTD. | Director/Board Member | 01-03-2022 |
| CENTESSA PHARMACEUTICALS PLC | Director/Board Member | 01-07-2022 |
Eerdere bekende functies van Mathias Hukkelhoven
| Bedrijven | Functie | Einde |
|---|---|---|
| Bristol-Myers Squibb (Israel) Ltd. | General Counsel | 01-07-2021 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | General Counsel | 01-01-2009 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | - |
Opleiding van Mathias Hukkelhoven
| Radboud University Nijmegen | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| COMPUGEN LTD. | Health Technology |
| CENTESSA PHARMACEUTICALS PLC | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
| Bristol-Myers Squibb (Israel) Ltd. |
